What are the Historical Developments and Current Growth Metrics of the Intrauterine Devices Market?
The intrauterine devices market has seen considerable growth due to a variety of factors.
• Over the past years, there has been a noticeable upsurge in the intrauterine devices market size. Speculations project it to rise from $3.96 billion in 2024 to $4.17 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.3%.
Several factors have contributed to this surge during the historic period, such as initiatives in family planning, women's empowerment, long-acting reversible contraception (larc), its excellent contraceptive efficacy, affordability, minimized side effects, and promotion by healthcare practitioners.
What Is The Projected Growth Of The Intrauterine Devices Template Market?
The intrauterine devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations suggest a stable expansion of the intrauterine devices market in the upcoming years. An increase to$4.94 billion by 2029 at a compound annual growth rate (CAGR) of 4.3% is expected. Several factors contributing to this projected growth include growing awareness and education, global health initiatives, preference for non-hormonal alternatives, increased availability of healthcare, tailor-made contraceptive options, services catering to the sexual health needs of young people, and incorporation with primary healthcare services. The forecast period will also see trends such as creation of frameless IUDs, innovation of biodegradable IUDs, improvements in user-friendly insertion mechanisms, provision of contraceptive counseling services, and research into non-contraceptive health advantages.
What Are The Key Drivers Fueling Growth In The Intrauterine Devices Market?
The growth of the intrauterine devices market is set to be fueled by the rising number of unplanned pregnancies. Defined as pregnancies that are neither desired nor planned, such as when no further children are wanted, they are a major factor propelling the market. Intrauterine devices (IUDs) offer a highly effective contraception method that alters the uterine environment, making it less favorable for sperm to fertilize an egg. As per statistics shared by the United Nations Population Fund, a US-based agency that focuses on sexual and reproductive health, there are approximately 121 million unintended pregnancies worldwide every year, as of March 2022. Furthermore, it is projected that unintended pregnancies in Afghanistan will reach 4.8 million by 2025. This escalation paired with the rising number of working women contributes greatly to the growth of the intrauterine devices market. Intrauterine Devices Market Driver: Growth Stimulated by Greater Participation of Women in Workforce
What Are The Principal Market Segments In The Global Intrauterine Devices Industry?
The intrauterine devices market covered in this report is segmented –
1) By Product: Hormonal Intrauterine Device, Copper Intrauterine Device
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years
3) By End-User: Hospitals, Gynecology Clinics, Community Healthcare, Other End Users
Subsegments:
1) By Hormonal Intrauterine Device: Levonorgestrel-Releasing IUD (e.g., Mirena, Kyleena, Skyla), Progestin-Based IUD
2) By Copper Intrauterine Device: Standard Copper IUD (e.g., ParaGard), Mini Copper IUD
Pre-Book The Intrauterine Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Intrauterine Devices Market?
Top-tier entities in the intrauterine devices industry are introducing innovative solutions like the IUB Ballerine, aimed at providing women a more efficient and convenient contraceptive method. IUB Ballerine is a long-term reversible contraceptive free from hormones and composed of a flexible nickel/titanium alloy framework carrying copper beads. These beads discharge copper ions into the uterus, forming an inhospitable environment for sperm and hence thwarting pregnancy. For example, in December 2022, Consilient Health Ltd., a pharmaceutical firm situated in the UK, unveiled a futuristic intrauterine device (IUD), known as IUB Ballerine. This promising new birth control method surpasses conventional methods in several ways. It grants a long-standing, reversible, and hormone-free solution that is crafted to be sphere-shaped, superior in comfort, and straightforward in its usage. This ground-breaking IUD possesses a distinctive three-dimensional ball-like design, constructed with copper beads on a flexible Nitinol frame. It's meant to conform to the uterus, thus lowering the possibilities of expulsion and fundal perforation during insertion. In addition, it marks a substantial step forward in intrauterine contraception, promising enhanced safety and simplicity of use.
Who Are the Key Players In The Intrauterine Devices Market?
Major companies operating in the intrauterine devices market report are:
• Cardinal Health Inc.
• Pfizer Inc.
• Merck and Co. Inc.
• AbbVie Inc.
• Bayer AG
• Abbott Laboratories
• Medtronic plc.
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Perrigo Company plc.
• CooperSurgical Inc.
• BIOTRONIK Inc.
• HLL Lifecare Limited
• ANI Pharmaceuticals
• Actavis GmbH
• DKT International Inc.
• Nipro Medical Corporation
• Pfm medical Inc.
• Besins HealthCare Limited
• Pregna International Limited
• SCITECH Medical Inc.
• Viatris Inc.
• Medicines360
• Afaxys Inc.
• Access Vascular Inc.
• OCON Medical Ltd.
• Agile Therapeutics Inc.
• SMB Corporation of India
• Eurogine S.L.
What Are The Regional Insights Into The Intrauterine Devices Market?
North America was the largest region in the intrauterine devices market in 2024. The regions covered in the intrauterine devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
